Phase 1 Transplant Recipient Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients

Solid Organ Transplant ComplicationsSolid Organ Transplant RecipientsSolid Organ Transplant Rejection

Francisco Hernández Oliveros10 enrolled1 locationNCT06997471

Recruiting

Phase 1

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell NeoplasmAllogeneic Hematopoietic Stem Cell Transplant Recipient

City of Hope Medical Center53 enrolled1 locationNCT04177004

Recruiting

Phase 1Phase 2

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient

City of Hope Medical Center80 enrolled1 locationNCT03354728